Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Shares Issued (2017 - 2025)

Rockwell Medical (RMTI) has disclosed Shares Issued for 12 consecutive years, with $7.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued rose 115.32% year-over-year to $7.8 million, compared with a TTM value of $11.6 million through Sep 2025, up 54.91%, and an annual FY2024 reading of $10.2 million, down 31.49% over the prior year.
  • Shares Issued was $7.8 million for Q3 2025 at Rockwell Medical, up from $3.8 million in the prior quarter.
  • Across five years, Shares Issued topped out at $13.8 million in Q3 2023 and bottomed at $107000.0 in Q4 2021.
  • Average Shares Issued over 4 years is $4.1 million, with a median of $2.9 million recorded in 2024.
  • Peak annual rise in Shares Issued hit 244.99% in 2024, while the deepest fall reached 73.62% in 2024.
  • Year by year, Shares Issued stood at $107000.0 in 2021, then soared by 926.17% to $1.1 million in 2023, then surged by 244.99% to $3.8 million in 2024, then soared by 106.34% to $7.8 million in 2025.
  • Business Quant data shows Shares Issued for RMTI at $7.8 million in Q3 2025, $3.8 million in Q4 2024, and $3.6 million in Q3 2024.